Evidence map›Paper›PMID 33619126›Full record

ArticleMolecular and cellular biology2021

The S-Phase Cyclin Clb5 Promotes rRNA Gene (rDNA) Stability by Maintaining Replication Initiation Efficiency in rDNA.

Mayuko Goto, Mariko Sasaki, Takehiko Kobayashi

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  6. Article
  7. Review
  8. Molecular and cellular biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mayuko GotoInstitute for Quantitative Biosciences, University of Tokyo, Tokyo, Japan.
Mariko SasakiInstitute for Quantitative Biosciences, University of Tokyo, Tokyo, Japan sasakim@iqb.u-tokyo.ac.jp tako2015@iqb.u-tokyo.ac.jp.
Takehiko KobayashiInstitute for Quantitative Biosciences, University of Tokyo, Tokyo, Japan sasakim@iqb.u-tokyo.ac.jp tako2015@iqb.u-tokyo.ac.jp.ORCID 0000-0002-7990-3741
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of replication origins is important for complete duplication of the genome, but the effect of origin activation on the cellular response to replication stress is poorly understood. The budding yeast rRNA gene (rDNA) forms tandem repeats and undergoes replication fork arrest at the replication fork barrier (RFB), inducing DNA double-strand breaks (DSBs) and genome instability accompanied by copy number alterations. Here, we demonstrate that the S-phase cyclin Clb5 promotes rDNA stability. Absence of Clb5 led to reduced efficiency of replication initiation in rDNA but had little effect on the number of replication forks arrested at the RFB, suggesting that arrival of the converging fork is delayed and forks are more stably arrested at the RFB. Deletion of

Indexed as

Cyclin BDNA-Binding ProteinsDNA DamageDNA, FungalDNA ReplicationDNA, RibosomalGenes, rRNAGenomic InstabilityReplication OriginSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsS PhaseCLB5 protein, S cerevisiaeCyclin BDNA-Binding ProteinsDNA, FungalDNA, RibosomalSaccharomyces cerevisiae ProteinsClb5genome instabilityreplication fork arrestreplication originribosomal RNA gene

Identifiers

PMID33619126
PMCPMC8088266
OpenAlexW3133441310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.